Evidence map›Paper›PMID 27810974›Full record

ArticleBMJ open2016

Using a simple point-prevalence survey to define appropriate antibiotic prescribing in hospitalised children across the UK.

Myriam Gharbi, Katja Doerholt, Stefania Vergnano, Julia Anna Bielicki, Stéphane Paulus, Esse Menson, Andrew Riordan, Hermione Lyall, Sanjay Valabh Patel, Jolanta Bernatoniene and 5 more

Abstract read
In one paragraph

Article in BMJ open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Point prevalence survey of antibiotics in a pediatric tertiary hospital in the Republic of Panama.Revista panamericana de salud publica = Pan American journal of public health · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Use of broad-spectrum antibiotics in children diagnosed with multisystem inflammatory syndrome temporarily associated with SARS-CoV-2 infection in Poland: the MOIS-CoR study.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Myriam GharbiNIHR Health Protection Research Unit Antimicrobial Resistance and Healthcare Associated Infection-Department of Primary Care and Public Health, Imperial College London, London, UK.
Katja DoerholtPaediatric Infection Diseases, St George's Hospital NHS Trust, London, UK.
Stefania VergnanoInstitute for Infection and Immunity-Paediatric Infectious Diseases Research Group, St. George's University of London, London, UK.
Julia Anna BielickiInstitute for Infection and Immunity-Paediatric Infectious Diseases Research Group, St. George's University of London, London, UK.
Stéphane PaulusPaediatric Infectious Diseases and Immunology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
Esse MensonDepartment of General Paediatrics, Evelina London Children's Hospital, London, UK.
Andrew RiordanPaediatric Infectious Diseases and Immunology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
Hermione LyallDepartment of Infectious Diseases, St Mary's Hospital Imperial College Healthcare NHS Trust, London, UK.
Sanjay Valabh PatelPaediatric Infectious Diseases and Immunology, Southampton Children's Hospital, Southampton, UK.
Jolanta BernatonienePaediatric Infectious Disease and Immunology, University Hospitals Bristol NHS Foundation Trust, Bristol Royal Hospital for Children, Bristol, UK.
Ann VersportenDepartment of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO) University of Antwerp, Antwerp, Belgium.
Maggie HeginbothomNational Public Health Service for Wales, Cardiff, UK.
Herman GoossensDepartment of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO) University of Antwerp, Antwerp, Belgium.
Mike SharlandPaediatric Infection Diseases, St George's Hospital NHS Trust, London, UK.
ARPEC project Group members

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe National Health Service England, Commissioning for Quality and Innovation for Antimicrobial Resistance (CQUIN AMR) aims to reduce the total antibiotic consumption and the use of certain broad-spectrum antibiotics in secondary care. However, robust baseline antibiotic use data are lacking for hospitalised children. In this study, we aim to describe, compare and explain the prescription patterns of antibiotics within and between paediatric units in the UK and to provide a baseline for antibiotic prescribing for future improvement using CQUIN AMR guidance.

methodsWe conducted a cross-sectional study using a point prevalence survey (PPS) in 61 paediatric units across the UK. The standardised study protocol from the Antibiotic Resistance and Prescribing in European Children (ARPEC) project was used. All inpatients under 18 years of age present in the participating hospital on the day of the study were included except neonates.

resultsA total of 1247 (40.9%) of 3047 children hospitalised on the day of the PPS were on antibiotics. The proportion of children receiving antibiotics showed a wide variation between both district general and tertiary hospitals, with 36.4% ( 95% CI 33.4% to 39.4%) and 43.0% (95% CI 40.9% to 45.1%) of children prescribed antibiotics, respectively. About a quarter of children on antibiotic therapy received either a medical or surgical prophylaxis with parenteral administration being the main prescribed route for antibiotics (>60% of the prescriptions for both types of hospitals). General paediatrics units were surprisingly high prescribers of critical broad-spectrum antibiotics, that is, carbapenems and piperacillin-tazobactam.

conclusionsWe provide a robust baseline for antibiotic prescribing in hospitalised children in relation to current national stewardship efforts in the UK. Repeated PPS with further linkage to resistance data needs to be part of the antibiotic stewardship strategy to tackle the issue of suboptimal antibiotic use in hospitalised children.

Indexed as

Drug PrescriptionsDrug UtilizationHospitalizationHospitalsPediatricsPractice Patterns, Physicians'AdolescentAnti-Bacterial AgentsCarbapenemsChildChild, HospitalizedChild, PreschoolCross-Sectional StudiesDrug Resistance, MicrobialFemaleHealth Care SurveysAnti-Bacterial AgentsCarbapenemsPenicillanic AcidPiperacillinPiperacillin, Tazobactam Drug CombinationAntimicrobials resistanceBenchmarkingPaediatric practiceQuality indicatorsSurveillance

Identifiers

PMID27810974
PMCPMC5129034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.